Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors.

Zhou, Jian-Guo; Yang, Jie; Jin, Su-Han; Xiao, Siyu; Shi, Lei; Zhang, Ting-You; Ma, Hu; Gaipl, Udo S

Zhou, Jian-Guo; Yang, Jie; Jin, Su-Han; Xiao, Siyu; Shi, Lei; Zhang, Ting-You; Ma, Hu; Gaipl, Udo S.

Afiliación

Zhou JG; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yang J; Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany.
Jin SH; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Xiao S; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Shi L; Department of Orthodontics, Affiliated Stomatological Hospital of Zunyi Medical University, Zunyi, China.
Zhang TY; Department of Clinical Laboratory, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Ma H; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Gaipl US; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Front Oncol ; 10: 1147, 2020.

Article en En | MEDLINE | ID: mdl-32850325

Palabras clave

GEO; The Cancer Genome Atlas; relapse; risk score model; testicular germ cell tumors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google